Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • Nanoveu Secures $2 Million to Fast-Track Commercial Launch of ECS-DoT Chip and AIoT Platform
    Nanoveu Secures $2 Million to Fast-Track Commercial Launch of ECS-DoT Chip and AIoT Platform
    • News

  • Archer Unlocks Cryogenic Sensor Breakthrough for Quantum Computing
    Archer Unlocks Cryogenic Sensor Breakthrough for Quantum Computing
    • News

  • EGL Secures $1.9M PFAS Plant Contract as Demand for Clean-Up Technologies Surges
    EGL Secures $1.9M PFAS Plant Contract as Demand for Clean-Up Technologies Surges
    • News

  • RocketDNA Secures Major Aerial Tech Contract with Vault Minerals at WA Gold Site
    RocketDNA Secures Major Aerial Tech Contract with Vault Minerals at WA Gold Site
    • News

  • BirdDog Boosts Buy-Back Offer by 40% Ahead of ASX Delisting Vote
    BirdDog Boosts Buy-Back Offer by 40% Ahead of ASX Delisting Vote
    • News

  • AML3D Launches High-Tech U.S. Facility to Power Submarine Supply Chain
    AML3D Launches High-Tech U.S. Facility to Power Submarine Supply Chain
    • News

  • Vection Enters $520K Agritech Deal to Build AI-Powered Farming Robot
    Vection Enters $520K Agritech Deal to Build AI-Powered Farming Robot
    • News

  • Unith Achieves Strong Growth in Platform Usage and Strategic Partnerships
    Unith Achieves Strong Growth in Platform Usage and Strategic Partnerships
    • News

  • FBR and Samsung Heavy Industries Execute Engineering Service Agreement for Shipbuilding Automation Project
    FBR and Samsung Heavy Industries Execute Engineering Service Agreement for Shipbuilding Automation Project
    • News

  • Bioxyne Lifts FY2025 Revenue Forecast as Psychedelics and Pharma Push Gains Pace
    Bioxyne Lifts FY2025 Revenue Forecast as Psychedelics and Pharma Push Gains Pace
    • News

Live Verdure keen to tap into the beauty market with hemp based skincare line in development

  • In News
  • March 10, 2022
  • Samantha Freidin
Live Verdure keen to tap into the beauty market with hemp based skincare line in development

The Australian skin care products market is forecast to reach over $300 million by 2025. 

That’s a lot of moisturiser… And plant based nutraceutical and skin care company Live Verdure (ASX: LV1) is keen to cash in. 

The Company’s hemp based “8 Seeds” skincare brand has had a face-lift with a reformulation for their multiple products under development.

At the helm of the line’s development is Live Verdure’s General Manager of Skincare, former Managing Director of Loreal, Mark Tucker. Under Tucker’s guidance the Company has progressed in their plans to bring the range to market. 

A pre-production run of four products is now underway with a further nine products in development. These products are a facial moisturiser with SPF, a facial serum, cleansing oil and body repair creme all with hemp seed oil as the active ingredient. 

Hemp seed oil is becoming a trending skin care ingredient touted for its ability to restore moisture and softness to the skin whilst providing key vitamins. Hemp is also a proven anti-inflammatory which is a main determinant in LV1’s decision to include it in a secondary range specifically formulated for skin conditions such as acne, eczema, psoriasis and roseacea. 

Packaging is set to be ordered this quarter while product samples are being tested for the US and UK markets. The Company is seeking to run a soft launch to their existing databse in Q3 FY22. Following that, the products will be sold through various channels including key online retailers, bricks and mortar stores and via Live Verdure’s own direct-to-customer database. 

“It’s exciting to see our hemp-based skin care products coming to life and I am confident that consumers will love using the products, which is key to developing brand-loyal users,” said Mark Tucker. “When combining the unique qualities in hemp seed oil and our high-standard formulations, 8 Seeds products will deliver effective skincare solutions across the targeted market segments. Utilising both local and international chemists and manufacturers also ensures our product performance is at the highest level. And with the largest market size in the USA and UK, we are entering a space that can generate substantial incremental revenue in comparison to the local market.”

For the half year ended 31st December 2021, Live Verdure reported an unaudited online sales revenue of $509,000 with a repeat customer rate of 23.7%. The Company has $2.4 million in cash at hand, giving them just over 3 quarters of funding.

  • About
  • Latest Posts
Samantha Freidin
Samantha Freidin is a business journalist at Emerald Financial whilst also completing a Masters of Marketing and Digital Communications at Monash University.
Latest posts by Samantha Freidin (see all)
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial - September 1, 2022
  • How this company is developing medtech to support Indigenous community health - August 22, 2022
  • A round of ap-paws for PharmAust, changing the ruff prognosis for dogs with lymphoma - August 17, 2022
  •  
  •  
  •  
  •  
  • 13 seeds
  • 8 seeds
  • asx lv1
  • live verdure
  • loreal
  • lv1
  • mark tucker
  • nutraceutical
  • skincare
  • News

Leave a Comment

You must be logged in to post a comment.

  • About
  • Latest Posts
Samantha Freidin
Samantha Freidin is a business journalist at Emerald Financial whilst also completing a Masters of Marketing and Digital Communications at Monash University.
Latest posts by Samantha Freidin (see all)
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial - September 1, 2022
  • How this company is developing medtech to support Indigenous community health - August 22, 2022
  • A round of ap-paws for PharmAust, changing the ruff prognosis for dogs with lymphoma - August 17, 2022

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Samantha Freidin
Samantha Freidin is a business journalist at Emerald Financial whilst also completing a Masters of Marketing and Digital Communications at Monash University.
Latest posts by Samantha Freidin (see all)
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial - September 1, 2022
  • How this company is developing medtech to support Indigenous community health - August 22, 2022
  • A round of ap-paws for PharmAust, changing the ruff prognosis for dogs with lymphoma - August 17, 2022
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.